- Home
- SNGX vs SGN Comparison
SNGX vs SGN Comparison
Compare SNGX & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- SGN
- Stock Information
- Founded
- SNGX 1987
- SGN 2019
- Country
- SNGX United States
- SGN United States
- Employees
- SNGX N/A
- SGN N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- SGN
- Sector
- SNGX Health Care
- SGN
- Exchange
- SNGX Nasdaq
- SGN Nasdaq
- Market Cap
- SNGX 4.3M
- SGN 3.8M
- IPO Year
- SNGX 1987
- SGN 2023
- Fundamental
- Price
- SNGX $2.78
- SGN $1.64
- Analyst Decision
- SNGX Strong Buy
- SGN
- Analyst Count
- SNGX 1
- SGN 0
- Target Price
- SNGX $6.00
- SGN N/A
- AVG Volume (30 Days)
- SNGX 22.2M
- SGN 672.4K
- Earning Date
- SNGX 08-14-2025
- SGN 08-12-2025
- Dividend Yield
- SNGX N/A
- SGN N/A
- EPS Growth
- SNGX N/A
- SGN N/A
- EPS
- SNGX N/A
- SGN N/A
- Revenue
- SNGX N/A
- SGN $391,126.00
- Revenue This Year
- SNGX N/A
- SGN N/A
- Revenue Next Year
- SNGX N/A
- SGN N/A
- P/E Ratio
- SNGX N/A
- SGN N/A
- Revenue Growth
- SNGX N/A
- SGN N/A
- 52 Week Low
- SNGX $1.09
- SGN $0.44
- 52 Week High
- SNGX $5.40
- SGN $36.70
- Technical
- Relative Strength Index (RSI)
- SNGX 59.82
- SGN 54.05
- Support Level
- SNGX $2.32
- SGN $1.30
- Resistance Level
- SNGX $2.99
- SGN $1.85
- Average True Range (ATR)
- SNGX 0.69
- SGN 0.21
- MACD
- SNGX 0.02
- SGN 0.01
- Stochastic Oscillator
- SNGX 38.10
- SGN 65.57
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.